FB pixel

UPDATE: Cross Match disputes Suprema’s claims in infringement suit, says ITC findings still valid

Categories Biometric R&D  |  Biometrics News  |  Trade Notes
 

Cross Match has issued a statement to say that the Federal Circuit has in fact affirmed that the U.S. International Trade Commission’s determination that Suprema and its reseller Mentalix infringe Cross Match’s U.S. Patent No. 5,900,993.

According to the company, the Federal Circuit has also affirmed that the ITC’s finding that the patent is valid. Further, says the company, the ITC’s determination that Cross Match’s U.S. Patent No. 7,203,344 and U.S. Patent No. 7,277,562 are valid and enforceable patents remains unchanged.

This challenges an announcement from Suprema earlier this week, in which the South Korean company said the Federal Circuit had given it a “favorable” ruling in this infringement case.

“As a leading innovator in the industry, we are very pleased that the Federal Circuit agreed with the ITC that Suprema and Mentalix infringe Cross Match’s patent,” Cross Match General Counsel, Kathryn Hutton said. ”While Suprema claims it no longer sells the infringing RealScan-10 product in the United States, the fact remains that any scanners which infringe the ’993 patent are still barred from importation. There has been no adjudication that Suprema has successfully designed around our patent.”

According to Cross Match, the Federal Circuit noted that the evidence lead the ITC to conclude Suprema (1) “was willfully blind to the ’344 patent, (2) studied and emulated Cross Match’s products before willfully blinding itself to the infringing nature of Mentalix’s activities, and (3) actively encouraged those activities.” Op.10. While the Federal Circuit determined that the ITC did not have authority to ban from importation certain Suprema products that the ITC found infringed the ’344 patent because the direct infringement occurs after the products are imported, it did “not address the Commission’s other findings on the ’344 patent.” Op.26. The Federal Circuit indicated that such post-importation infringement issues should be brought before “the applicable federal court forum.”  To that end, Cross Match has an infringement suit against Suprema and Mentalix pending in the U.S. District Court for the Eastern District of Texas.

The Federal Circuit affirmed the ITC’s determination that integrated biometric capture devices with computer processing functionality, such as Cross Match’s SEEK, practice the ’562 patent.

“This decision upholds important intellectual property rights and provides Cross Match with the basis for future enforcement activities where necessary,” Hutton said.

Article Topics

 |   |   | 

Latest Biometrics News

 

UK train stations trial Amazon emotion recognition on passengers

Amazon-powered AI cameras are now being used to monitor and analyze passengers’ emotions by employing a combination of “smart” CCTV…

 

IDloop launches 3D contactless fingerprint biometrics scanner

Germany-based biometric security company IDloop has introduced the CFS flats, an optical contactless fingerprint scanner that incorporates 3D imaging. This…

 

Clearview, Axess, 3DiVi, Next, Facephi target international growth

Several biometrics providers with established footholds have struck deals to expand into new geographies, while an access control multinational is…

 

House committee wants to check TSA’s digital identity homework

The U.S. House Homeland Security Committee has advanced legislation that would require the Transportation Security Authority (TSA) to produce a…

 

Vermont governor rejects privacy law that would be among strongest in US

The governor of Vermont says the state’s proposed data protection law is too risky, and has returned H.121, “An act…

 

Meta scores biometric privacy lawsuit win over Facebook non-users

A BIPA class action lawsuit against social media giant Meta has been quashed. The suit alleged that Meta Platforms Inc….

Comments

3 Replies to “UPDATE: Cross Match disputes Suprema’s claims in infringement suit, says ITC findings still valid”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Read This Week

Featured Company

Biometrics Insight, Opinion

Digital ID In-Depth

Biometrics White Papers

Biometrics Events